Cell Reports:用维生素D治疗糖尿病

2015-03-23 叶予 生物通

二型糖尿病和心脏病常常同时发生,近年来人们发现这两种疾病与维生素D缺乏有关。 慢性炎症会引起胰岛素抵抗和堵塞动脉的斑块,是二型糖尿病和心脏病的根源。华盛顿大学的科学家们发现维生素D能够防止这样的炎症,而且维生素D不足会影响一种关键的免疫细胞。这项研究发表在三月十九日的Cell Reports杂志上。 研究显示,免疫细胞缺乏维生素D受体,会使小鼠抵抗胰岛素的作用,导致体内的葡萄糖过量。

二型糖尿病和心脏病常常同时发生,近年来人们发现这两种疾病与维生素D缺乏有关。

慢性炎症会引起胰岛素抵抗和堵塞动脉的斑块,是二型糖尿病和心脏病的根源。华盛顿大学的科学家们发现维生素D能够防止这样的炎症,而且维生素D不足会影响一种关键的免疫细胞。这项研究发表在三月十九日的Cell Reports杂志上。 [pdf free]



研究显示,免疫细胞缺乏维生素D受体,会使小鼠抵抗胰岛素的作用,导致体内的葡萄糖过量。此外,小鼠血管中也会出现斑块累积。

“我们发现维生素D有助于调控葡萄糖代谢,这可以解释为何缺乏维生素D的人更容易患糖尿病,”文章的资深作者,华盛顿大学的副教授Carlos Bernal-Mizrachi说。“在我们的研究中,失活维生素D受体会引起糖尿病和动脉粥样硬化。反过来,恢复维生素D的水平应该可以起到治疗效果。”

研究人员还发现,维生素D不足会使单核细胞成为脂肪转运者。单核细胞是免疫系统中的一种白细胞。它们从骨髓进入血液的几天后,往往会移动到组织中,在那里成熟为巨噬细胞。

“失活单核细胞和巨噬细胞上的维生素D受体,会增强肝脏和动脉壁的炎症,” Bernal-Mizrachi说。“单核细胞附着到血管壁的能力也会提高,在那里释放出与糖尿病和心脏病有关的胆固醇和炎症性物质。” 补充足够的维生素D,也许能减少这些问题,避免心脏病和糖尿病的并发。

这是人们首次发现,缺乏维生素D的单核细胞会把脂肪带到血管壁。“我们知道,单核细胞成熟为巨噬细胞之后就能摄取胆固醇,”文章的共同第一作者,助理教授Amy E. Riek说。“但我们在实验中发现,在缺乏维生素D时,血液里的单核细胞也能吃掉并携带胆固醇。”

这一发现很重要,因为靶标血液中的物质比靶标血管壁中的物质容易得多。这项研究“为我们提供了潜在的治疗靶标,”Riek说。

研究人员将正常骨髓移植到出现了二型糖尿病和动脉粥样硬化的缺陷型小鼠中,成功降低了这些小鼠体内的炎症和血糖水平,让小鼠对胰岛素更加敏感。现在他们正在临床试验中用维生素D治疗二型糖尿病患者,希望能够避免一些并发症。

原始出处:

Jisu Oh, Amy E. Riek, Isra Darwech,et,al.Deletion of Macrophage Vitamin D Receptor Promotes Insulin Resistance and Monocyte Cholesterol Transport to Accelerate Atherosclerosis in Mice .Cell Reports.doi:10.1016/j.celrep.2015.02.043[pdf free]

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1869055, encodeId=72821869055e6, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Apr 23 17:19:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959306, encodeId=a51519593064d, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Oct 20 06:19:00 CST 2015, time=2015-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27113, encodeId=ac3a2e113dd, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Thu Jun 11 18:46:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20337, encodeId=bdac2033e1d, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:40:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18723, encodeId=bc8218e235f, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18724, encodeId=a7ac18e24d2, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18726, encodeId=b48d18e264e, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18672, encodeId=2139186e22e, content=这仅仅是基础研究,与临床不同, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Mar 23 20:02:00 CST 2015, time=2015-03-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1869055, encodeId=72821869055e6, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Apr 23 17:19:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959306, encodeId=a51519593064d, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Oct 20 06:19:00 CST 2015, time=2015-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27113, encodeId=ac3a2e113dd, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Thu Jun 11 18:46:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20337, encodeId=bdac2033e1d, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:40:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18723, encodeId=bc8218e235f, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18724, encodeId=a7ac18e24d2, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18726, encodeId=b48d18e264e, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18672, encodeId=2139186e22e, content=这仅仅是基础研究,与临床不同, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Mar 23 20:02:00 CST 2015, time=2015-03-23, status=1, ipAttribution=)]
    2015-10-20 维他命
  3. [GetPortalCommentsPageByObjectIdResponse(id=1869055, encodeId=72821869055e6, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Apr 23 17:19:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959306, encodeId=a51519593064d, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Oct 20 06:19:00 CST 2015, time=2015-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27113, encodeId=ac3a2e113dd, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Thu Jun 11 18:46:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20337, encodeId=bdac2033e1d, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:40:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18723, encodeId=bc8218e235f, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18724, encodeId=a7ac18e24d2, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18726, encodeId=b48d18e264e, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18672, encodeId=2139186e22e, content=这仅仅是基础研究,与临床不同, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Mar 23 20:02:00 CST 2015, time=2015-03-23, status=1, ipAttribution=)]
    2015-06-11 ljjj1053

    好好学习一下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1869055, encodeId=72821869055e6, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Apr 23 17:19:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959306, encodeId=a51519593064d, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Oct 20 06:19:00 CST 2015, time=2015-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27113, encodeId=ac3a2e113dd, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Thu Jun 11 18:46:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20337, encodeId=bdac2033e1d, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:40:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18723, encodeId=bc8218e235f, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18724, encodeId=a7ac18e24d2, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18726, encodeId=b48d18e264e, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18672, encodeId=2139186e22e, content=这仅仅是基础研究,与临床不同, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Mar 23 20:02:00 CST 2015, time=2015-03-23, status=1, ipAttribution=)]
    2015-04-11 x35042875

    AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1869055, encodeId=72821869055e6, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Apr 23 17:19:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959306, encodeId=a51519593064d, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Oct 20 06:19:00 CST 2015, time=2015-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27113, encodeId=ac3a2e113dd, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Thu Jun 11 18:46:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20337, encodeId=bdac2033e1d, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:40:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18723, encodeId=bc8218e235f, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18724, encodeId=a7ac18e24d2, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18726, encodeId=b48d18e264e, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18672, encodeId=2139186e22e, content=这仅仅是基础研究,与临床不同, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Mar 23 20:02:00 CST 2015, time=2015-03-23, status=1, ipAttribution=)]
    2015-03-24 sky0909

    学习啦

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1869055, encodeId=72821869055e6, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Apr 23 17:19:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959306, encodeId=a51519593064d, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Oct 20 06:19:00 CST 2015, time=2015-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27113, encodeId=ac3a2e113dd, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Thu Jun 11 18:46:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20337, encodeId=bdac2033e1d, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:40:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18723, encodeId=bc8218e235f, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18724, encodeId=a7ac18e24d2, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18726, encodeId=b48d18e264e, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18672, encodeId=2139186e22e, content=这仅仅是基础研究,与临床不同, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Mar 23 20:02:00 CST 2015, time=2015-03-23, status=1, ipAttribution=)]
    2015-03-24 sky0909

    学习啦

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1869055, encodeId=72821869055e6, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Apr 23 17:19:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959306, encodeId=a51519593064d, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Oct 20 06:19:00 CST 2015, time=2015-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27113, encodeId=ac3a2e113dd, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Thu Jun 11 18:46:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20337, encodeId=bdac2033e1d, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:40:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18723, encodeId=bc8218e235f, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18724, encodeId=a7ac18e24d2, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18726, encodeId=b48d18e264e, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18672, encodeId=2139186e22e, content=这仅仅是基础研究,与临床不同, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Mar 23 20:02:00 CST 2015, time=2015-03-23, status=1, ipAttribution=)]
    2015-03-24 sky0909

    学习啦

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1869055, encodeId=72821869055e6, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Thu Apr 23 17:19:00 CST 2015, time=2015-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959306, encodeId=a51519593064d, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Tue Oct 20 06:19:00 CST 2015, time=2015-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27113, encodeId=ac3a2e113dd, content=好好学习一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Thu Jun 11 18:46:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20337, encodeId=bdac2033e1d, content=AKI对心衰临床治疗意义重大,但依然需要研究检验其适用性, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 22:40:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18723, encodeId=bc8218e235f, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18724, encodeId=a7ac18e24d2, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18726, encodeId=b48d18e264e, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=sky0909, createdTime=Tue Mar 24 21:14:00 CST 2015, time=2015-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=18672, encodeId=2139186e22e, content=这仅仅是基础研究,与临床不同, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Mar 23 20:02:00 CST 2015, time=2015-03-23, status=1, ipAttribution=)]
    2015-03-23 lovetcm

    这仅仅是基础研究,与临床不同

    0

相关资讯

AJOG:IVF结局与女性体内维生素D含量无关

体内25-羟基维生素D的缺乏与许多亚健康以及疾病状态相关,如肿瘤、心血管疾病、代谢病和免疫系统疾病。近几年许多研究表明,女性体内维生素D含量与生育息息相关。已有证据表明,维生素D缺乏与不良妊娠结局密不可分,如子痫前期。但是目前关于不孕不育使用体外受精治疗时,其女性体内维生素D水平与受孕率和结局的关系的数据十分匮乏,因此Franasiak JM等人进行了一项回顾性队列研究,以探究在进行整倍

JAMA Intern Med:降血压用维生素D?没用!

低水平的维生素D与高血压 (BP)和未来的心血管事件有关。补充维生素D是否能降低血压,以及哪一类患者能够对该疗法产生应答 (BP)尚不清楚。 我们通过检索MEDLINE、CINAHL EMBASE、Cochrane Central Register of Controlled Trials和http://www.ClinicalTrials.com网站收纳了相关研究文章和以前的评论并运用谷歌来搜

Maturitas:揭秘维生素D和抑郁症发病之间的因果关联

近日,来自西澳大学的研究人员通过研究表示,维生素D的缺乏或许在个体后期生活中并不会引发抑郁症,但却是个体抑郁的一个标志;研究者表示,截止到目前为止很多研究证据都表明维生素D的缺失同抑郁症的发生存在一部分的因果关系。 Almeida教授说道,我们都知道大脑中包含许多维生素D的受体,这就说明维生素D在调节部分大脑功能中扮演着重要角色,因此就存在这种可能性,即低水平的维生素D会引发抑郁症,这说起来合情

Gut:维生素D为何能对抗结肠癌

很多观察性研究发现,血液中维生素D含量越高,患结肠癌的风险越低。一项新研究可能找到了其中一个原因。 恶性肿瘤中不仅有癌细胞,还有很多其他种类的细胞,其中一些细胞能影响肿瘤变大或扩散的速度。其中有一群免疫系统细胞,名叫T淋巴细胞或T细胞,它们能攻击肿瘤细胞,限制它们的发展。含有更多T细胞的肿瘤,预后情况更好。 这项发表在《内脏》(Gut)杂志上的研究调查了318名结直肠癌患者和624名匹配的

Maturitas:维生素D与抑郁症发病之间的因果关联

近日,来自西澳大学的研究人员通过研究表示,维生素D的缺乏或许在个体后期生活中并不会引发抑郁症,但却是个体抑郁的一个标志;研究者表示,截止到目前为止很多研究证据都表明维生素D的缺失同抑郁症的发生存在一部分的因果关系。 Almeida教授说道,我们都知道大脑中包含许多维生素D的受体,这就说明维生素D在调节部分大脑功能中扮演着重要角色,因此就存在这种可能性,即低水平的维生素D会引发抑郁症,这说起来

Ginekol Pol:多囊卵巢综合征的女性患者的维生素D浓度与肥胖的关系

目的研究多囊卵巢综合症(PCOS)女性维生素D代谢浓度与荷尔蒙激素水平对出现的腹部和gynoidal型肥胖的影响。材料与方法26个PCOS女性患者(19~49岁,BMI:26.8~53.8 kg/m2),出现显著的腹部和gynoidal型肥胖者被招募作为研究对象。使用双能吸光光度法测量人体机体组分,测定空腹血清25-羟基维生素D、瘦蛋白 (来普汀)、葡萄糖、胰岛素、内环境平衡的评估模型(HOMA)